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Synopsis ....................................
High rates of human immunodeficiency virus (HIV)
infection among jail and prison inmates suggest that
HIV prevention efforts should focus on incarcerated
populations. Overcrowding, the high prevalence of
injection drug use, and other high-risk behaviors
among inmates create a prime opportunity for public
health officials to affect the course of the HIV
epidemic if they can remedy these problems.
Yet, along with the opportunity, there are certain
obstacles that correctional institutions present to
public health efforts. The various jurisdictions have
differing approaches to HIV prevention and control.
Whether testing should be mandatory or voluntary,
whether housing should be integrated or segregated
by HIV serostatus, and whether condoms, bleach, or
clean needles should be made available to the
prisoners, are questions hotly debated by public
health and correctional officials.
Even accurate assessment of risk-taking within the
institutions leads to controversy, as asking questions
could imply acceptance of the very behaviors
correctional officials are trying to prevent. Education
and risk-reduction counseling are the least controver-
sial and most widely employed modes of prevention,
but the effectiveness of current prevention efforts in
reducing HIV transmission in this high-risk popula-
tion is largely undetermined.
RESOURCES for preventing human immunodefi-
ciency virus (HIV) transmission are extremely lim-
ited, so education and prevention programs should
concentrate efforts on populations at the greatest risk
for infection. The higher rates of infection among the
incarcerated, as compared with the general public,
indicate that HIV prevention programs should target
persons serving sentences in correctional facilities.
Recent studies show that female inmates, inmates
ages 25 or younger, and African American and
Hispanic inmates carry the greatest risks for infec-
tion; program planners should consider their special
needs.
In this report, we estimate the magnitude of the
HIV problem in prisons and jails, describe the major
strategies for HIV prevention among inmates, define
structural barriers to implementing certain preventive
strategies, and identify factors that should be
considered in serious attempts to reduce high-risk
behavior in current and in former inmates. We con-
clude that to prevent the transmission of HIV among
incarcerated persons and from those who serve time
in corrections facilities to members of the general
population, officials from the public health, correc-
tions, drug treatment, and legislative systems must
collaborate in program planning and implementation.
Magnitude of the Problem
Prisons and jails. During 1990, an estimated 1.1
million adults and approximately 6,000 juveniles
were confined to local jails or to State or Federal
prisons (1). As of 1989, an additional 94,000
juveniles, ages 10-17, were held in juvenile facilities
(2). Jails are facilities designed for detaining people
awaiting trial and for people serving sentences of less
than 1 year. Prisons are for convicted felons serving
sentences longer than 1 year. Juvenile facilities may
include public or private detention centers, training
schools, shelters, halfway houses, and the like. Some
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Table 1. Profile of adult inmates, percentage distribution of
inmate population by correctional system
Federal State Jails
Category 1991 1991 2 1989 3
Race:
White, non-Hispanic ......... 38 35 39
Black, non-Hispanic ......... 30 46 42
Hispanic .................... 28 17 17
Other ....................... 4 2 2
Sex:
Male ....................... 92 95 90.5
Female ..................... 8 5 9.5
Age:
24 years or younger ........ 9 22 34
25-34 years ................ 36 46 43
35 years or older ........... 55 33 23
Offense:
Violent offenses (murder,
rape, robbery, and so
forth) ...................... 17 47 23
Property offenses (burglary,
theft, fraud, and so forth) 14 25 30
Drug offenses (possession,
trafficking, and so forth).... 58 21 23
Public order offenses 4 ...... 9 7 23
Other ....................... 2 ... ...
Total population (number) ..... 54,006 711,643 395,554
Median maximum sentence
(months) ..................... 84 108 6
1 Data reported June 1991-sentenced inmates only (U.S. Department of
Justice, Federal Bureau of Prisons' telefax, May 6, 1994).
2 Data reported June 1991 (4).
3 Data reported 1989 (37).
4 Public order offenses include Federal-weapons, immigration, tax law
violations, and so forth; State-weapons, driving under the influence (DUI), and
so forth; Jails-weapons, obstruction of justice, DUI, and so forth.
juveniles are, however, detained in jails pending
transfer to juvenile authorities.
Incarcerated adults are predominately male (ap-
proximately 93 percent); although from 1983 to 1991,
the female population grew by 141 percent, compared
with 80 percent in the male segment (3,4). As of
1991, white males constituted the largest proportion
of Federal prison inmates and African American
males constituted the largest proportion of inmates in
Federal and State prisons and the jail systems (4). On
average, county and local jail inmates are younger
than prison inmates (5).
Drug offenses account for the single largest
number of Federal crimes. More violent crimes were
committed by, and longer sentences were imposed
upon, inmates in the State system. Property crimes
such as burglary, theft, or fraud account for a larger
percentage of jail sentences (table 1).
In 1989, the juvenile offender held in a public
facility was most likely a black male between the
ages of 14 and 17 in custody for a delinquent offense,
such as a property crime or a crime against another
person. The private juvenile facility resident, on the
other hand, was most likely a white male, ages 14-
17, and in custody for a nondelinquent offense such
as running away from home, playing hooky, or for
unruly behavior (2) (table 2).
HIV and AIDS. Acquired immunodeficiency syn-
drome (AIDS) was first reported among U.S. prison
inmates in 1983 (6). By 1992, there were an
estimated 195 AIDS cases for every 100,000 persons
incarcerated in a State or Federal prison, as compared
with 18 cases for every 100,000 within the entire
United States population (7). Between 1989 and
1992, seroprevalence studies conducted in 46 correc-
tional facilities in 19 metropolitan areas found the
median rate to be 1.7 percent, ranging from 0.0
percent to 20.6 percent for women and from 0.0
percent to 14.8 percent for men. The range for
homosexual and bisexual men was 9.4 to 34.5
percent; it ranged from 0.6 to 43.1 percent for
persons who injected drugs (8).
HIV positivity rates of inmates entering State
prisons have ranged from 0.0 percent in Idaho and
Iowa during 1986 and 1987 to 18 percent in New
York during 1989 (9,10). In 1991, 51.2 percent of all
inmates in the State correctional systems reported
having been tested for HIV, with a 2.2 percent
seropositive rate (11). The seroprevalence rate for the
Federal prisons in 1991 was less than 1.0 percent,
based on blinded samples taken from entering in-
mates and from testing inmates at various times dur-
ing the year (Mr. Tom Metzger, Office of Public
Affairs, Federal Bureau of Prisons, September 1993).
In 1989, rates of infection among women were as
high as 25.8 percent in New York City jail facilities.
Drug use among inmates. High rates of HIV
infection are not surprising in a population charac-
terized by heavy involvement with illicit drug use.
Although sharing of injection equipment is a well-
documented mode of HIV transmission, the use of
other illicit drugs is also an associated risk for the
disease. This is due, in part, to the fact that many
drug users exchange sex for drugs or money to
support their habits, and do so without the protection
of condoms (12-14). In 1989, jail inmates nationwide
were twice as likely as those in the general
population to have ever used drugs and were seven
times more likely to have been users at that time.
Seventy-eight percent had used drugs during their
lifetime, 44 percent had used drugs in the month
before their current offense, 30 percent daily or
almost daily, and 27 percent were under the influence
when they committed their current offense (15).
In 1991, 79 percent of State prison inmates indi-
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cated they had at some time used illicit drugs; 21
percent were serving time for committing a drug-
related offense (11). Approximately 2.5 percent of
those inmates who reported having tested positive for
HIV were drug users, compared with 0.8 percent of
those who had never used drugs (16). Of the inmates
who had used drugs in the month before their of-
fense, 40 percent had injected primarily heroin, 28
percent other opiates, and 28 percent cocaine (11).
The HIV seropositivity rates were highest among
inmates who reported they had used drugs in the
month before their offense (2.8 percent), had injected
drugs (4.9 percent), or had ever shared needles with
other drug users (7.1 percent). Twelve percent of all
inmates and 20 percent of those who used drugs in
the month before their offense reported that they had
shared a needle (11).
Despite the large number of drug users within
incarcerated populations, drug-treatment programs are
either not always available to inmates or are not
utilized. Data on 16,998 intravenous drug users
(IDUs) not in treatment were collected from 1987 to
1989. Of the 83 percent who reported spending some
time in jail or prison, 81 percent had never
participated in formal drug treatment while incarce-
rated (17).
In the "1992 Update: HIV/AIDS in Correctional
Facilities" (7), the State correctional systems re-
ported that an estimated 19 percent of male inmates
and 15 percent of female inmates had a history of
IDU. Among these systems, the percentage of in-
mates reported having received any type of drug
treatment was 35 percent for males and 83 percent
for females. In this 1992 report, 19 of 38 large jail
systems reported that 27 percent of males and 34
percent of females had a history of IDU; 9 percent
and 30 percent, respectively, had received treatment.
Even when services are available and are used by
inmates, the treatment may not be appropriate to
change the behaviors of the drug users or to prevent
relapses of those persons who have made positive
changes. For example, in 1989, of those convicted
jail inmates who had used a major drug daily in the
month before their offense, 48 percent had, at some
time, participated in a drug abuse treatment
program-27 percent, once; 8 percent, twice; 9
percent, three to five times; and 4 percent six or more
times. Eighteen percent indicated they were most
recently treated while incarcerated (15).
In 1992, 55 percent of 503 large jail jurisdictions
were providing some type of drug treatment; how-
ever, only 8 percent of the population of approx-
imately 362,000 had participated in the programs
(18). The Federal Bureau of Prisons reported in 1994
Table 2. Profile of juvenile detention population, percentage
distribution, by public and private facility, 1989 (2)
Category Total Public Private
Race:
White ......................... 48 40 60
Black ......................... 37 42 29
Hispanic ...................... 13 16 8
Other ......................... 2 2 3
Sex:
Male .......................... 78 88 70
Female ....................... 22 12 30
Total nondelinquents 1 ........... 27,813 3,086 24,727
Total delinquents ................ 66,132 53,037 13,095
Delinquent offenses:
Person crimes ................. 25 27 19
Serious property crimes........ 28 29 26
Other property crimes ......... 17 14 28
Alcohol, drug-related crimes.... 13 12 14
Public order offenses .......... 5 5 2
Technical violations ............ 8 9 2
Other ......................... 4 3 9
Total 1-day counts ........ ...... 93,945 56,123 37,822
1 Nondelinquents include detainees held for reasons not considered crimes.
These include dependency, neglect, abuse, emotional disturbance, retardation,
and other.
that 52 percent of its inmates had substance abuse
problems and that 70 percent had committed drug
offenses (19). In 1991, the General Accounting Office
(GAO) reported that only 1 percent of Federal
inmates who had moderate to severe drug abuse
problems had received appropriate treatment and that
less than half of the treatment slots were filled. Also,
for inmates who did complete the intensive treatment,
there were no aftercare services in place to assist
them in remaining drug free. The GAO report con-
cluded that, particularly since the inmates may lack
motivation to seek treatment, the lack of outreach and
program information to prison staff may have
contributed to the small number of inmates enrolling
in the programs (20).
Among State facility inmates in 1991 who had
used drugs during the month before their last offense,
48 percent had participated in drug treatment after
receiving their current sentence. Of these, 31 percent
had been in treatment before entering prison; 25
percent had been in such a program once or twice;
and 6 percent, three or more times. Of these 48
percent, 32 percent had participated in group
counseling, 12 percent in self-help and peer group
counseling, and 7 percent in drug education pro-
grams. Only 11 percent had received inpatient drug
treatment, and 5 percent had received individual
counseling (11). According to a 1991 GAO report,
less than 20 percent of State inmates who had drug
abuse problems were receiving treatment (21).
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Inmates who do participate in drug treatment
programs while incarcerated quite often relapse upon
release (22). In a 1993 study of 55 recently paroled
HIV-positive New Yorkers, 67 percent had relapsed
into using at least one drug of choice; 84 percent had
participated in a drug treatment program in prison.
Post-release relapse was found to be associated with
poor housing status, limited social support, lack of
drug treatment, and less frequent visits with case
managers (23). These linkages to larger social issues
suggest that if prevention efforts are to be effective,
access to followup services needs to be addressed, as
indicated in a 1993 memo from Lisa W. Scheckel,
Acting Director, Center for Substance Abuse Treat-
ment (CSAT), published in the CSAT communique
(22):
... offenders leaving a structured, institutional
setting endure great stress-often with limited
coping skills-and have a critical need to learn
how to prevent relapse ....
... a comprehensive approach is needed-many
drug-abusing offenders lack adequate education,
job skills, medical care, family support, or even
a home as a backdrop for remaining sober or
drug free.
The risky behaviors that lead to HIV infection may
not stop once a person is behind bars. There is
evidence that sex and drug use take place within
correctional facilities. In a 1988 study of six South
Carolina correctional institutions, more than 40
percent of inmates reported knowledge of needle-
sharing, and more than 60 percent reported sexual
activity among inmates in the past year. Eight percent
of the responding inmates had injected drugs them-
selves; 40 percent had shared drug paraphernalia
occasionally (24).
A Montreal study of recent IDUs (injected in the
past 6 months) found that 8 percent of the males and
11 percent of the females had sexual relations while
in jail. Those persons who indicated involvement in
prostitution were more likely to have participated in
sex while in jail (26 percent of 114 males and 15
percent of 99 females) and were significantly more
likely to have been HIV positive at the time of the
study (27 percent males and 9 percent females) (25).
Few studies have been conducted to determine
whether HIV seroconversions take place during
incarceration. Data from a study conducted between
1988 and 1990 of male inmates within the Illinois
Department of Corrections support the opinion that
transmission occurs within the prison. At baseline
testing in 1988, 47 of 1,309 inmates were found to be
HIV positive. One year later, blood samples were
taken and 80 persons were found to be seropositive, 8
of whom had been HIV negative at baseline (26). A
study conducted in the Maryland prison system in
1987 concludes that seroconversion in two inmates
most likely took place within the prison (27).
Special Populations
Youth. Although young people, in general, seem to
be informed about AIDS and HIV transmission, they
are less aware of risk-reduction strategies. Incarce-
rated youth may be even less knowledgeable than
public high school students about reducing risk of
transmission. In a 1988 San Francisco study of high
school students and youths in a juvenile detention
center, 85 percent of the students acknowledged
condom use as a means of reducing transmission,
compared with 75 percent of the incarcerated teens.
Only 62 percent of the incarcerated youths, compared
with 80 percent of high school students, recognized
that abstinence from sex lowered the risk of infection,
and only 56 percent, compared with 72 percent of the
high schoolers, were aware that avoiding sex with an
IDU lowered the risk of infection (28).
In addition to being less knowledgeable about risk-
reduction methods, incarcerated youth are at much
greater risk for acquiring HIV because of their sex
and drug behaviors. Fifty-two percent of the adoles-
cents in the detention center were age 12 or younger
when they had first had sex, compared with 26
percent of the high school sample. Ninety-nine
percent of the incarcerated adolescents reported being
sexually active; 73 percent reported two or more sex
partners in the past year; and only 29 percent of those
who were sexually active reported consistent condom
use. This compares with 28 percent, 8 percent, and 37
percent, respectively, of the high school adolescents.
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Thirteen percent of the incarcerated adolescents and 4
percent of the students reported having injected drugs
(28).
In a 1987 survey of male and female inmates in the
Cook County, IL, Department of Corrections, 17
percent of those who reported drug use with a needle
were younger than 25 years. The survey also
concluded that among females, younger inmates were
more likely to have a lifetime history of injection
drug use (29).
Of the 78 percent of jail inmates in 1989 who had
ever used drugs, 33 percent were between the ages of
18 and 24 (15). A study of males in a mid-Atlantic
juvenile detention center in 1986 revealed that 16
percent of the inmates were serving time for a
substance abuse offense and 4 percent for a sex
offense; 85 percent had prior offense histories (30).
A history of sexually transmitted diseases (STDs)
has also been associated with risk for HIV
seropositivity. A person with signs or symptoms of
STD has usually engaged in activities that increase
risk for HIV infection. A 1981 study of STDs in 100
females in a juvenile detention center found that 81
percent complained of vaginal discharge. Gonorrhea
was found in 18 percent, and chlamydia in 20
percent, of detainees tested. Most (68 percent) of the
respondents used no method of contraception (31).
A study of incarcerated female adolescents in Los
Angeles County found that from 1989 to 1992 there
was an increase in awareness of HIV high-risk
behavior. However, though reported condom use for
vaginal intercourse increased, STDs were even more
prevalent in this population in 1992 than in previous
years (32). Childhood sexual abuse has implications
for HIV prevention in adolescents, as many of the
high-risk behaviors displayed in adolescence are a
result of earlier abuse. In 1984, the American
Humane Association classified 13 percent of the
official reports of child abuse and neglect as "sexual
maltreatment," accounting for more than 100,000
children. This could be just the "tip of the iceberg"
since many incidents are probably never reported. An
estimate in 1984 was that "between 46,000 and
92,000 boys were victimized each year and the
number of girls may be three times higher" (33).
Girls who have been sexually abused sometimes
act out their hostilities through self-destructive
behaviors such as running away from home, sexual
identity conflicts, substance abuse, suicide attempts,
and compulsive sexual behavior. Sometimes these
problems continue into adulthood (33). Boys who
have been victimized tend to become more aggressive
in their "acting out." Manifestations of this behavior
might include criminal acts such as molestation and
rape (34). In an FBI study of 41 serial rapists, more
than 50 percent reported they had repeated the abuse
they received as children (35).
Additionally, drug use has been indicated as a
direct result of abuse in at least one study of 34
adolescents, 6 or 8 years after they had been sexually
abused. Alcohol and other drugs had been given to
the child by the abuser to suppress tension,
symptoms, and thoughts related to the abusive
episodes. The children continued to use the alcohol
and drugs to lessen the anxiety related to the
exploitation (36).
Although there are few data on this subject, the
correctional system population includes many sur-
vivers of sexual abuse. In a 1989 jail survey, 44
percent of females and 13 percent of males reported
having been sexually or physically abused in the past
(37); more than 31 percent of the women had been
abused before age 18. Eighty-six percent of these
inmates had used drugs in the past, compared with 77
percent of those inmates who indicated they had not
been abused. Seventy-two percent of the abused
inmates reported they had used drugs regularly,
compared with 56 percent who had not been abused
(15). Similarly, in 1991, 43 percent of females and 12
percent of males in State prison systems reported
having been sexually or otherwise physically abused;
one-third of the women indicated it had happened
before they had reached the age of 18 (11). HIV
prevention strategies will need to address not only
risk-reduction methods, but also victimization issues
and barriers to behavior change such as lack of self-
esteem and low motivation for self-protection (38).
Women. The number of incarcerated women more
than doubled between 1983 and 1991, from approx-
imately 35,000 to 84,000 (3). Although HIV infection
in women is on the increase, the rate in men remains
higher in the general U.S. population. The rate of
infection in the incarcerated population, however, is
higher in females than in males. In the 1991 survey
of State inmates, those who were ever tested for HIV
and reported the results, women (3.3 percent) were
more likely than men (2.1 percent) to have tested
positive. Supporting these results is a study that
assessed HIV seroprevalence in 10 prisons and jails
throughout the United States between 1989 and 1992;
women had higher rates of infection than men in 9 of
the 10 systems (8).
High rates of HIV infection among incarcerated
women are curious, given the higher rate of infection
among men in the general population. The in-
congruity may be explained by the greater likelihood
of women to be arrested for crimes related to drug
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use. In 1989, one of three jailed women were there
for a drug-related offense, as compared with one of
five men. From 1986 to 1991, there was a 432
percent increase in the number of women in the State
prisons serving a sentence for a drug offense; in
1991, 82 percent of those women who committed a
drug-related offense had used drugs in the past month
(11).
Sixty-four percent of female inmates in the Federal
prisons in 1991 were serving time for drug-related
offenses (39). The Cook County, IL, study finds
female inmates twice as likely as male inmates to
report injection drug use (29). In 1991, female prison
inmates were also more likely to have used a needle
to inject drugs (7 percent) and to share a needle (10
percent) than men (5 and 7 percent, respectively).
Women in Federal custody are mostly of child-
bearing age, 20-34. Eighty percent have children and
70 percent of those are single parents. Many have
either had a child just prior to incarceration or are
pregnant and give birth while incarcerated (40). Six
percent of women entered the State prison system
pregnant in 1991 (11). Along with the male inmates'
needs for services and education, females need
additional counseling related to perinatal HIV trans-
mission and pediatric AIDS.
People of color. African Americans and Hispanics
are still disproportionately affected by the AIDS
epidemic. As of December 1992, they accounted for
51 percent of all AIDS cases reported in the United
States, although together these two groups make up
only 21 percent of the total population. Of the
cumulative AIDS cases reported by the correctional
systems in 1992 that included race or ethnicity
information (81 percent of the total), 44 percent were
African American, 42 percent were Hispanic, and 14
percent were white (7).
Vlahov's study of 10 prison systems throughout the
United States found that overall HIV rates for
nonwhites (4.8 percent) were higher than those for
whites (2.5 percent). Of the State prison inmates in
1991 who had ever been tested for HIV and reported
the results, 3.7 percent of Hispanic inmates and 2.6
percent of black inmates tested positive, compared
with 1.1 percent of white inmates. The most alarming
rates of infection were found among Hispanic
women, who, with a rate of 6.8 percent, were more
than three times as likely as white women (1.9
percent) to be infected with HIV (11).
In 1985, another study of the San Francisco high
school adolescents found that black and Latino youth
were almost twice as likely as white adolescents to
have misconceptions about HIV and its transmission.
This lack of knowledge was related to a lower
perception of risk for being infected with HIV (41).
Impact on the community. By 1991, the average
daily population of State and Federal prisons had
more than doubled from 329,000 in 1980 to 804,000
(42), and the jail population had increased by 75
percent to 427,000 from 244,000 in 1983 (18). The
New York State prison population, which rose from
20,000 in 1979 to 59,000 in 1991, is a vivid
representation of this trend (43). The increase is at
least partially the result of mandatory sentencing for
drug-related crimes. Inmates sentenced for a drug-
related offense accounted for 44 percent of the
increase in the prison population from 1986 to 1991
(11).
At the end of 1992, State and Federal correctional
facilities were between 23 and 46 percent, respec-
tively, above the planned capacity. Fifteen percent of
the State facilities had been cited for overcrowded
conditions, 14 percent for conditions related to
medical care, and 13 percent related to staffing (44).
The overcrowded facilities impact on the rotation
of inmates in and out of the correctional system. For
example, during 1991 the jail systems admitted and
released approximately 10 million persons; the State
systems admitted almost 700,000, and approximately
430,000 were released into the general population (4).
In 1990, the Federal system admitted and released
approximately 33,000 (45). This "revolving door"
phenomenon has implications for HIV prevention and
control for the communities into which the inmates
are released. In 1991, 4,000 of the estimated 8,000
New York State inmates who were HIV-positive were
released (43).
The assumption that HIV infection in prisons is of
little concern to those who are not incarcerated
ignores crucial facts (46):
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Prison walls effectively restrain criminals only
for short time spans; they neither delimit nor
contain the public health dilemmas of HIV
infection. How we care for the incarcerated will
in the future have direct effect on needed
clinical and public health services in the
community.
Overcrowding and the high HIV infection rate has
a significant impact on the correctional system, and
subsequently, the taxpayer, because the costs for
treating inmates with AIDS can be overwhelming.
For instance, the District of Columbia Correctional
System estimates a yearly cost of $23,300 just to
keep an inmate locked up; for an inmate with full-
blown AIDS, the cost soars to $60,000 (47).
The correctional systems are caught in a
"Catch-22" situation. If they treat the AIDS patients,
the costs are astronomical. If they do not provide
treatment, lawsuits are often brought against the jails
and prisons on behalf of the inmates-litigations that
can cost millions of dollars in awards for negligence.
In the end, from a purely cost-benefit perspective, it
is less expensive to treat the infected inmates than to
ignore them.
What's Being Done
Education and prevention programs. Education and
prevention counseling are at present the least
controversial ways to control the spread of HIV
infection. According to the "1992 Update: HIV/AIDS
in Correctional Facilities," 98 percent of the State
systems, 90 percent of the large jail systems, and the
Federal system provide some type of HIV prevention
and education program (7).
Whether these programs are effectively reaching
the prison and jail populations for whom they are
designed is unclear. One study of AIDS knowledge
and attitudes of prisoners found that inmates had
basic knowledge of AIDS equal to their same-sex
counterparts in the general population (48). Nonethe-
less, more than half of the incarcerated drug abusers
studied in 58 county jails did not know the length of
the HIV incubation period or that an infected person
can transmit the virus when they have no symptoms
(49). Additionally, 44 percent of inmates in a North
Carolina women's prison believed they were likely to
be exposed to HIV in prison and 81 percent believed
that AIDS education programs should discuss female-
to-female transmission (50).
In addition to giving needed services to the
correctional system population, HIV education and
prevention counseling should be explored as a cost-
reduction tool. More than 470,000 inmates entered
the State prisons during 1990 (1). Using 2.2 percent
as an estimated HIV seroprevalence rate for State
prisons (11), approximately 10,340 persons would
have tested positive. The Centers for Disease Control
and Prevention (CDC) estimates that the cost of
providing HIV prevention counseling to seropositive
persons is approximately $92 per person per session,
and $51 for HIV testing ($134 total); for seronegative
persons, it is approximately $42 and $4 ($46 total).
The estimated cost for providing prevention counsel-
ing to all 470,000 inmates (assuming all are at risk
and agree to be tested) would be $22.5 million, with
an average cost of $2,179 for identifying and
counseling each seropositive person ($22.5 million-
10,340).
This cost may seem high; however, in 1991 the
estimated lifetime cost of treating a person with HIV
was $85,000 (51). Based on these figures, 39 persons
could be identified and counseled for the lifetime cost
of treating a single case ($85,000 + $2,179).
Consequently, if, as a result of these services, even 1
of the 39 persons avoided transmitting HIV, the
benefit would outweigh the costs.
Testing. Some prison officials have responded to the
HIV epidemic by implementing mandatory HIV
testing of inmates, either upon entrance into the
system or during incarceration. The intent behind
mandatory testing has been the subsequent segrega-
tion of those who tested positive from those who test
negative. However, some correctional officials be-
lieve it is important to identify inmates who need
such early intervention, prevention, and medical
services as intensive risk reduction counseling, CD4
monitoring, drug therapy, psychosocial support serv-
ices, access to experimental therapies, and clinical
trials (7).
As of 1992, seven State correctional systems in the
United States required mandatory testing upon entry;
eight required testing upon entry and for all current
inmates; one upon entry and release; and two upon
entry, release, and for all current inmates. Twenty-
four States offered "purely voluntary" testing; they
included the six States that represent 65 percent of
the AIDS cases-California, Florida, Illinois, New
Jersey, New York, and Texas (7).
Comparisons of results of blind seroprevalence and
voluntary testing of male inmates in Wisconsin and
Oregon revealed that seroprevalence rates did not
differ between the two testing results (mandated or
voluntary testing). In addition, prisoners at highest
risk for infection (that is, IDUs) were more likely to
request an HIV antibody test, discounting some
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prison officials' fears that those most at risk would
avoid testing if it were voluntary (52).
In a more recent study, however, between April
1990 and June 1992, 7.5 percent of the New York
male prison inmates who volunteered to be tested
were seropositive. This result compares with 14.9
percent positive rate in a blinded seroprevalence
study conducted on inmates entering the New York
prison system in 1990. The authors of that study
suggest that at least some HIV-infected inmates in
New York's prisons do not seek testing for fear of
mistreatment should their status become known.
However, it was also pointed out that some persons
want to be tested to prove to their fellow inmates that
they are negative, which could drive up the testing
rate. This theory was supported by a sample of tested
inmates who chose to convert from anonymous to
confidential status. Fifty-nine percent of those per-
sons were found to be positive to receive early
intervention services; 79 percent of the negative
persons converted to receive a written negative test
result (53).
Among the arguments against any of kind of HIV
testing is the lack of confidentiality available to those
inmates who test positive and the implications that a
positive result may have on their release. The Federal
Bureau of Prisons requires HIV testing for all inmates
upon their release (7). Seropositive inmates are asked
to notify their "significant others" of the results. If
an inmate refuses to be tested, he or she may remain
incarcerated. The Bureau strongly encourages re-
leased inmates who test positive to notify their sex
partners of their status. Where applicable, health
departments are notified, and they then initiate
partner notification for releasees in their area (54).
Availability of condoms, bleach, and needles. One
dilemma that prison officials face in the AIDS
pandemic is how to prevent the transmission of HIV
infection without acknowledging that drug use and
sexual relations occur within correctional facilities or
to appear to condone such activities. Injection drug
use and unprotected sex within the prison walls have
clear implications for HIV prevention. As of March
1993, only four jail systems and two State prison
systems had policies of making condoms available
within the institutions: District of Columbia, Mis-
sissippi, New York City, Philadelphia, San Francisco,
and Vermont. In these correctional systems, there
have been very few problems with condoms being
used as weapons or for smuggling contraband,
contrary to the arguments made by critics of condom
availability policies (7).
None of the U.S. correctional systems have made
bleach or clean needles available to inmates. In some
correctional facilities, however, there is de facto
bleach availability since it is widely used for normal
cleaning functions (7). Though needles are not
officially available inside prisons-jails, they can often
be acquired through the prison black market.
Generally, these needles can be obtained only at
exorbitant costs ($34 inside one Canadian facility)
and come with no guarantee of safety (55). As a
result, shared needles are often the only needles that
are available to prisoners, thus increasing their
chances of acquiring the HIV infection. Since
tattooing is common among prisoners, this can also
be a source of HIV transmission. There have been at
least two AIDS cases related to tattooing with
unsterilized needles in a prison (56).
From a public health perspective, making condoms,
bleach, and clean needles available within the
correctional facilities would reduce the risk of HIV
transmission in this setting. However, since security
and law enforcement are higher priorities of the
policy-making officials in correctional facilities, it is
unlikely that these practices will be widely adopted as
responses to HIV infection (57).
Segregated housing. The primary intent behind
mandatory testing is the subsequent segregation of
those who receive positive results from those who
test negative. This policy fosters the false assumption
that if inmates are in the general population, they are
not infected. The resulting sense of security may lead
to an increase in high-risk behaviors among persons
who incorrectly assumes themselves or others to be
free of HIV infection (58).
As of November 1992, five State or Federal prison
systems (10 percent) still permanently segregated
inmates with AIDS, down from nine in 1990. Two
systems segregated all known HIV-infected inmates,
including asymptomatic persons. Most other systems
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either make a case-by-case determination based on
medical, security, or other reasons (59 percent) or
include persons with HIV in the general population
without restrictions (28 percent) (7).
One argument for segregation is that infected
prisoners need to be isolated for their own safety. A
report by the Correctional Association of New York
indicated that a diagnosis of HIV infection often
leads to isolation within or exclusion from the general
population. Infected inmates are sometimes shunned
or attacked (30). In some cases, inmates may pressure
the systems to house the seropositive inmates
separately. For instance, in focus group interviews of
40 female prisoners, 94 percent felt that all inmates
should be given HIV antibody tests upon entering the
system, and 56 percent believed that seropositive
inmates should be segregated from the general
population (50).
On the other hand, some argue that segregating
inmates with HIV is undesirable because it labels the
inmates and makes them vulnerable to assaults,
discrimination, and disparate treatment. The isolation
is depressing for inmates and is counter productive to
promoting health or behavior changes (40). Systems
that use voluntary or random test results to segregate
inmates support the erroneous assumption that in-
mates in the general population are not infected. The
resulting false sense of security may lead to an
increase in high-risk behaviors among a population
that incorrectly assumes itself to be free of HIV
infection (58). An opponent to segregation summed it
up: "Automatic segregation of prisoners with AIDS
is no more desirable or defensible in an institutional
context than it is in the society as a whole" (59).
Summary and Implications for Prevention
Prisons and jails are critically important bat-
tlegrounds in the fight against HIV infection. While
all inmates appear to be at elevated risk, the rates of
HIV infection and risky behavior among incarcerated
women and inmates younger than 25 suggest that
particularly vigorous HIV prevention efforts should
be mounted in facilities for these groups. Risk-
reduction strategies should be tailored for African
American and Hispanic inmates, for those with
histories of prostitution, and for those involved in
injection drug use.
Mandatory sentencing for drug offenses has surely
changed the composition of the correctional institu-
tions and increased substantially the risk of all
inmates. Before and during an inmate's incarceration,
risk accrues from sharing needles and works in
injection drug use, and risk is compounded by
unprotected sexual intercourse. Given the link be-
tween drug use and incarceration, it is evident that an
HIV prevention program in a correctional facility
must deal with drug dependency issues.
Often, a prisoner's stay in a correctional facility is
brief. This temporal constraint complicates all re-
habilitation efforts, including those focusing on drug
problems. Corrections officials, already challenged by
the task of limiting HIV transmission within their
facilities, cannot afford to ignore the consequences of
interrupted drug treatment. Lacking continued sup-
port, former inmates quickly relapse into drug use. It
is necessary that public health officials and correc-
tions officers work with substance abuse agencies to
ensure that drug treatment continues to be available
beyond the confines of correctional settings.
Similarly, other aspects of the broader social
context that lead to incarceration have implications
for HIV prevention, and they underscore the need for
linkages between the corrections system and com-
munity services. Social services that may be required
to support HIV prevention interventions with released
prisoners include support groups, case management,
and educational programming.
Even within the correctional system, collaborative
action is hampered by the fragmentation of Federal,
State, and local jurisdictions. Cooperative planning
across systems is further impeded by a tangle of
ethical questions related to the conflicts between
individual and collective rights. Public health and
public safety officials have competing ideologies and
priorities. In order for those concerned to move
towards consensus, empirical evidence of the safety
and efficacy of contested prevention strategies is
needed. In some cases, legislative mandates must be
created or removed to allow such innovative interven-
tions to be implemented and evaluated.
Further studies must be conducted to elaborate the
full range of HIV programs in place in the
correctional system. One such current study, under
the auspices of the CDC, is using formative research
to describe and evaluate the quality of HIV-AIDS
prevention programs in a variety of incarceration
settings. Further studies need to be conducted to
determine the programs' impact on behavior. On a
broad front, the roles of prostitution, drug addiction,
poverty, limited life options, and previous trauma
must be better understood.
In addition to HIV-AIDS, other sexually transmit-
ted diseases and tuberculosis menace the health of
prisoners and, in turn, the public health. The daunting
challenges in this area present unparalleled oppor-
tunities to halt the progress of HIV transmission, to
improve the lives of prisoners and their families and
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partners, and to guard the safety of the general
population. If correctional and public health officials
can bridge barriers to coordinated action, they can
have a significant and lasting impact on the spread of
HIV-AIDS in the United States.
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